Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-02-27FDA Approved: PRIMAQUINE PHOSPHATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves a supplemental application for Primaquine Phosphate by Unichem Pharmaceuticals (USA), expanding the approved product's use/labe…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Single Low-dose Primaquine Efficacy and Safety. [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of a single low-dose primaquine for malaria.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014
A completed clinical trial update investigating artemether-lumefantrine for Plasmodium falciparum and chloroquine for Plasmodium vivax malar…
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Pyronaridine Artesunate-Ritonavir Drug-drug Interaction Study [Phase 1]
Phase 1 trial update evaluating drug-drug interaction with pyronaridine artesunate-ritonavir for malaria; results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablet [Phase 1]
Phase 1 bioequivalence trial comparing pyronaridine artesunate to the reference tablet for a to-be-marketed formulation; completed with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Optimizing Malaria Treatment for HIV-Malaria Co-infected Individuals [Phase 4]
Phase 4 trial update focused on optimizing malaria treatment in individuals co-infected with HIV.
-
FDA approval · 2022-12-07FDA Approved: DOXYCYCLINE — Original Application (Par Health USA, LLC)
FDA approved a generic doxycycline product under an original new drug application by Par Health USA, LLC (ANDA216690).
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Comparing Chemoprevention Approaches for School-based Malaria Control [Phase 4]
Phase 4 trial update comparing chemoprevention approaches for school-based malaria control completed.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Ivermectin-artemisinin Combination Therapy for Eradication of Malaria [Phase 4]
A Phase 4 clinical trial evaluating an ivermectin-artemisinin combination for malaria eradication is ongoing, with the status currently unkn…
-
FDA approval · 2022-10-25FDA Approved: PYRIMETHAMINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for pyrimethamine from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali [Phase 2]
Phase 2 trial of the Pfs230D1M-EPA/AS01 malaria transmission-blocking vaccine in Mali (children and family compound setting) has completed a…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan [Phase 4]
Phase 4 cluster randomized trial evaluating malaria rapid diagnostic tests used by community health workers in Afghanistan has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa... [Phase 1, Phase 2]
Phase I/II randomized trial evaluating PfSPZ-CVac malaria vaccination with pyrimethamine or chloroquine chemoprophylaxis; completed with pos…
-
FDA approval · 2022-07-11FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate from Aurobindo Pharma Limited.
-
FDA approval · 2022-07-07FDA Approved: HYDROXYCHLOROQUINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for HYDROXYCHLOROQUINE from Chartwell RX, LLC under an ANDA, making a generic version available.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2) [Phase 2]
A Phase 2 clinical trial evaluating a single low dose tafenoquine to reduce transmission of Plasmodium falciparum malaria in Mali has comple…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Safety and Efficacy of NF135 CPS Immunization [NA]
Clinical trial update for NF135 CPS immunization shows termination with posted results, involving malaria falciparum and controlled human ma…
-
FDA approval · 2022-05-03FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp. This action constit…
-
FDA approval · 2022-05-03FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for chloroquine phosphate from Amneal Pharmaceuticals of New York LLC. This action allows contin…
-
FDA approval · 2022-05-03FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for chloroquine phosphate from Rising Pharma Holdings, Inc. This approval authorizes the continued c…
-
FDA approval · 2022-05-03FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for CHLOROQUINE PHOSPHATE from Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon [Phase 4]
Phase 4 trial update assessing the efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in malaria.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria [Phase 4]
Phase 4 trial assessing the effectiveness and safety of two artemisinin-based combination therapies for malaria has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine [Phase 2, Phase 3]
Phase 2/3 trial comparing pyronaridine-artesunate to artemether-lumefantrine for malaria shows efficacy and safety data from completed study…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy [Phase 3]
Phase 3 randomized trial evaluating three artemisinin-based combination therapies for malaria in pregnancy has completed.